LIP
IMNM icon

Lighthouse Investment Partners’s Immunome IMNM Stock Holding History

Lighthouse Investment Partners’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,777
Closed -$513K – 465
2024
Q1 		$513K Buy
+20,777
New +$422K 0.02% 326

Other funds holding IMNM

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Lighthouse Investment Partners's IMNM Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Immunome (IMNM) in Q2 2024, closing a stake of 20,777 shares — an estimated $513K sold.

Lighthouse Investment Partners first reported a position in IMNM in Q1 2024 and held it in 1 quarter. The position peaked at $513K in Q1 2024. 113 funds tracked by Wall St. Rank hold IMNM as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Immunome position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 20,777 Immunome shares in Q2 2024, an estimated $513K.
  • Lighthouse Investment Partners first reported a position in Immunome in Q1 2024 and held it in 1 quarter.
  • Lighthouse Investment Partners's Immunome position peaked at $513K in Q1 2024.
  • 113 funds tracked by Wall St. Rank held Immunome as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.